Comparison of Long-Term Efficacy and Safety of Esketamine Nasal Spray Plus Oral Antidepressant in Younger Versus Older Patients With Treatment-Resistant Depression: Post-Hoc Analysis of SUSTAIN-2, a Long-Term Open-Label Phase 3 Safety and Efficacy Study-Reference-Cited by-同舟云学术

Comparison of Long-Term Efficacy and Safety of Esketamine Nasal Spray Plus Oral Antidepressant in Younger Versus Older Patients With Treatment-Resistant Depression: Post-Hoc Analysis of SUSTAIN-2, a Long-Term Open-Label Phase 3 Safety and Efficacy Study

Published:2021-10 Issue: Volume: Page:
ISSN:1064-7481
Container-title:The American Journal of Geriatric Psychiatry
language:en
Short-container-title:The American Journal of Geriatric Psychiatry

Author:

Ochs-Ross Rachel,Wajs Ewa,Daly Ella J.,Zhang Yun,Lane Rosanne,Lim Pilar,Drevets Wayne C.,Steffens David C.,Sanacora Gerard,Jamieson Carol,Hough David,Manji Husseini,Singh Jaskaran B.

Funder

Janssen Research and Development LLC

Publisher

Elsevier BV

Subject

Psychiatry and Mental health,Geriatrics and Gerontology

Reference29 articles.

1. Depression in late life: review and commentary;Blazer;J Gerontol Series A: Biol Sci Med Sci,2003

2. Remission in major depression: results from a geriatric primary care population;Azar;Int J Geriatr Psychiatry,2011

3. Partial response as a predictor of outcome in geriatric depression;Steffens;Am J Geriatr Psychiatry,2003

4. A systematic review of treatments for refractory depression in older people;Cooper;Am J Psychiatry,2011

5. Update on electroconvulsive therapy (ECT) in older adult;Kelly;J Am Geriatr Soc,2000

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Benefits and risks of esketamine nasal spray continuation in treatment-resistant depression;Biomarkers in Neuropsychiatry;2024-12

2. Dépression résistante aux traitements chez les personnes âgées;NPG Neurologie - Psychiatrie - Gériatrie;2024-09

3. Compassionate use of esketamine intranasal in patients with severe major depressive disorder resistant to the treatment;Journal of Psychopharmacology;2024-08-07

4. REVOLUTIONIZING DEPRESSION TREATMENT: A PARADIGM SHIFT OF KETAMINE THERAPY – A SYSTEMATIC REVIEW;Asian Journal of Pharmaceutical and Clinical Research;2024-08-07

5. What about the relevance of PIP of psychotropics in older psychiatric inpatients?;L'Encéphale;2024-07